MedTrace Logo

Decision Aid for Patients With Generalized Anxiety Disorder: Protocol for a Randomized Controlled Trial

NCT04364958 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2023-04-18

No results posted yet for this study

Summary

The main goal of this study is assess the effectiveness of a PtDA for patients with GAD.

Conditions

  • Generalized Anxiety Disorder
  • GAD

Interventions

OTHER

A web based-Patient Decision Aid (PtDA) (shown on the computer)

Patient decision aids (PtDAs) are tools that assist patients in making health decisions, when there is uncertainty about treatment choice, incorporating their personal preferences and values about the available treatment options. This PtDA will include information about GAD symptoms, diagnosis, causes, and benefits and risks associated to psychological and pharmacological treatments for GAD (based on the Clinical Practice Guidelines-GAD). It will also include a values clarification exercise, in which patients will have to rate the importance attributed to the different aspects of treatments (e.g., mode of administration, benefits, risks, time to improvement, probability of relapse).

OTHER

A web-based fact sheet (one page shown on the computer) with general information on mental health as a part of usual care.

Patients in the control group will receive a fact sheet (one page) with general information on mental health as a part of usual care provided by the Canary Islands Health Service.

Sponsors & Collaborators

  • Servicio Canario de Salud

    lead OTHER

Principal Investigators

  • Lilisbeth Perestelo Perez, PhD · Servicio de Evaluacion del Servicio Canario de la Salud

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-07
Primary Completion
2022-11-30
Completion
2023-04-13

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04364958 on ClinicalTrials.gov